CompaniesFovea Pharmaceuticals

Fovea Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

4

As Collaborator

0

Total Enrollment

1,149

By Phase

PHASE2: 3PHASE1: 1

By Status

COMPLETED: 3TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
Today
NCT00969293
NCT01319487
Hover over trial bars to see details

Recent Trials

NCT01319487Lead Sponsor
Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy
PHASE2Completed
267 participants
Started: May 31, 2011 · Completed: Jun 30, 2012
NCT01120132Lead Sponsor
Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis
PHASE2Completed
716 participants
Started: May 31, 2010 · Completed: Aug 31, 2010
NCT00969293Lead Sponsor
Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion
PHASE1Terminated
11 participants
Started: Sep 30, 2009 · Completed: Mar 31, 2012
NCT00833495Lead Sponsor
Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation
PHASE2Completed
155 participants
Started: Jan 31, 2009 · Completed: Mar 31, 2009
Related Companies
Sanofi Oct 2009----------------------------------------if You Believe Any Of This Information Is Incorrect
acquired
Fovea Pharmaceuticals | Biotech Hunter | Biotech Hunter